Champions Oncology, Inc. (CSBR) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Champions Oncology, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.438 Greetings. Welcome to the Champions Oncology third quarter fiscal year 2025 earnings 00:00:05.438 -- 00:00:09.123 call. At this time, all participants are in a listen-only mode. 00:00:09.123 -- 00:00:12.388 A question and answer session will follow the formal presentation. 00:00:12.388 -- 00:00:15.632 If anyone should require operator assistance during the conference, please press store 00:00:15.632 -- 00:00:19.838 zero on your telephone keypad. Please note, this conference is being recorded. 00:00:19.838 -- 00:00:24.184 I will now turn the conference over to your host, Ronnie Morris, Chief Executive Officer. 00:00:24.184 -- 00:00:26.424 You may begin. 00:00:29.849 -- 00:00:33.612 Good afternoon. I am Ronnie Morris, CEO of Champions Oncology. 00:00:33.612 -- 00:00:37.135 Joining me today is David Miller, our Chief Financial Officer. 00:00:37.135 -- 00:00:39.818 Thank you for joining us for our quarterly earnings call. 00:00:39.818 -- 00:00:43.521 Before I begin, I'll remind you that we're making forward-looking statements during today's 00:00:43.521 -- 00:00:47.344 call and that actual results could differ materially from what is described in those 00:00:47.344 -- 00:00:52.089 statements. Additional information on factors that could cause results to differ is available 00:00:52.089 -- 00:00:56.933 in our Forms 10-Q and Form 10-K. A reconciliation of non-GAAP financial measures that 00:00:56.933 -- 00:01:01.181 may be discussed during the call is to gap financial measures is available in the earnings 00:01:01.181 -- 00:01:02.683 release. 00:01:02.683 -- 00:01:07.970 Q3 marked a transformative quarter for Champions Oncology, underscored by our record 00:01:07.970 -- 00:01:12.996 revenue of $17 million and the successful closure of ou...